NO20060678L - Triazolopyrimidinderivater som glykogensyntase-kinase 3-inhibitorer - Google Patents

Triazolopyrimidinderivater som glykogensyntase-kinase 3-inhibitorer

Info

Publication number: NO20060678L
Authority: NO; Norway
Prior art keywords: optionally substituted; alkyl; alkyloxy; polyhaloci; polyhaloc
Prior art date: 2003-07-16

Application number

NO20060678A

Other languages

English (en)

Norwegian (no)

Inventor

Ludwig Paul Cooymans

Eddy Jean Edgard Freyne

Werner Constant Joha Embrechts

Christopher John Love

Marc Willems

Nele Vandermaesen

Peter Jacobus Johan Buijnsters

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-07-16

Filing date

2006-02-10

Publication date

2006-02-10

2006-02-10 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2006-02-10 Publication of NO20060678L publication Critical patent/NO20060678L/no

Links

239000003572 glycogen synthase kinase 3 inhibitor Substances 0.000 title 1
YWBFPKPWMSWWEA-UHFFFAOYSA-O triazolopyrimidine Chemical class BrC1=CC=CC(C=2N=C3N=CN[N+]3=C(NCC=3C=CN=CC=3)C=2)=C1 YWBFPKPWMSWWEA-UHFFFAOYSA-O 0.000 title 1
125000004093 cyano group Chemical group *C#N 0.000 abstract 6
125000000217 alkyl group Chemical group 0.000 abstract 4
125000003545 alkoxy group Chemical group 0.000 abstract 3
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 2
125000002485 formyl group Chemical group [H]C(*)=O 0.000 abstract 2
125000005843 halogen group Chemical group 0.000 abstract 2
229910052739 hydrogen Inorganic materials 0.000 abstract 2
239000001257 hydrogen Substances 0.000 abstract 2
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
125000004916 (C1-C6) alkylcarbonyl group Chemical group 0.000 abstract 1
125000003601 C2-C6 alkynyl group Chemical group 0.000 abstract 1
150000001204 N-oxides Chemical class 0.000 abstract 1
125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
125000005196 alkyl carbonyloxy group Chemical group 0.000 abstract 1
125000000304 alkynyl group Chemical group 0.000 abstract 1
150000001412 amines Chemical group 0.000 abstract 1
125000003118 aryl group Chemical group 0.000 abstract 1
125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
125000005842 heteroatom Chemical group 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
125000002911 monocyclic heterocycle group Chemical group 0.000 abstract 1
229910052757 nitrogen Inorganic materials 0.000 abstract 1
229910052760 oxygen Inorganic materials 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
125000003373 pyrazinyl group Chemical group 0.000 abstract 1
125000002098 pyridazinyl group Chemical group 0.000 abstract 1
125000004076 pyridyl group Chemical group 0.000 abstract 1
125000000714 pyrimidinyl group Chemical group 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
125000001424 substituent group Chemical group 0.000 abstract 1
229910052717 sulfur Inorganic materials 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Diabetes (AREA)
Hematology (AREA)
Endocrinology (AREA)
Dermatology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Oncology (AREA)
Emergency Medicine (AREA)
Obesity (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Rheumatology (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

NO20060678A 2003-07-16 2006-02-10 Triazolopyrimidinderivater som glykogensyntase-kinase 3-inhibitorer NO20060678L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP0350310		2003-07-16
PCT/EP2004/051455 WO2005012307A1 (en)	2003-07-16	2004-07-12	Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors

Publications (1)

Publication Number	Publication Date
NO20060678L true NO20060678L (no)	2006-02-10

Family

ID=34112425

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20060678A NO20060678L (no)	2003-07-16	2006-02-10	Triazolopyrimidinderivater som glykogensyntase-kinase 3-inhibitorer

Country Status (26)

Country	Link
US (2)	US7560458B2 (pt)
EP (1)	EP1658292B1 (pt)
JP (1)	JP2009514782A (pt)
KR (1)	KR20060120393A (pt)
CN (1)	CN100404536C (pt)
AP (1)	AP2006003486A0 (pt)
AR (1)	AR045698A1 (pt)
AT (1)	ATE370142T1 (pt)
AU (1)	AU2004260738B2 (pt)
BR (1)	BRPI0412596A (pt)
CA (1)	CA2531333A1 (pt)
DE (1)	DE602004008303T2 (pt)
DK (1)	DK1658292T3 (pt)
EA (1)	EA010109B1 (pt)
ES (1)	ES2290754T3 (pt)
IL (1)	IL173139A (pt)
JO (1)	JO2460B1 (pt)
MX (1)	MXPA06000540A (pt)
NO (1)	NO20060678L (pt)
NZ (1)	NZ545058A (pt)
PA (1)	PA8607001A1 (pt)
PL (1)	PL1658292T3 (pt)
PT (1)	PT1658292E (pt)
TW (1)	TW200524935A (pt)
WO (1)	WO2005012307A1 (pt)
ZA (1)	ZA200600385B (pt)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI329105B (en)	2002-02-01	2010-08-21	Rigel Pharmaceuticals Inc	2,4-pyrimidinediamine compounds and their uses
BR0313059B8 (pt)	2002-07-29	2021-07-27	Rigel Pharmaceuticals	composto, e, composição farmacêutica
ATE370142T1 (de) *	2003-07-16	2007-09-15	Janssen Pharmaceutica Nv	Triazolopyrimidinderivate als inhibitoren von glycogensynthasekinase-3
CN102358738A (zh)	2003-07-30	2012-02-22	里格尔药品股份有限公司	2,4-嘧啶二胺化合物及其预防和治疗自体免疫疾病的用途
TWI378923B (en) *	2003-08-15	2012-12-11	Novartis Ag	Pyrimidine derivatives
NZ546611A (en) *	2003-09-18	2010-02-26	Conforma Therapeutics Corp	Novel heterocyclic compounds as HSP90-inhibitors
MX2007003327A (es)	2004-09-20	2007-06-05	Xenon Pharmaceuticals Inc	Derivados heterociclicos, y su uso como mediadores de estearoil-coa desaturasa.
MX2007003319A (es)	2004-09-20	2007-06-05	Xenon Pharmaceuticals Inc	Derivados heterociclicos y su uso como agentes terapeuticos.
EP2269610A3 (en)	2004-09-20	2011-03-09	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
EP1799667B1 (en)	2004-09-20	2013-03-20	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives and their use as therapeutic agents
EP2289510A1 (en)	2004-09-20	2011-03-02	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
JP4958786B2 (ja)	2004-09-20	2012-06-20	ゼノン・ファーマシューティカルズ・インコーポレイテッド	複素環誘導体および治療薬としてのそれらの使用
MX2007003332A (es)	2004-09-20	2007-06-05	Xenon Pharmaceuticals Inc	Derivados heterociclicos y su uso como inhibidores de estearoil-coa-desaturasa.
DE602005023333D1 (de)	2004-10-15	2010-10-14	Takeda Pharmaceutical	Kinaseinhibitoren
US8153640B2 (en)	2004-10-29	2012-04-10	Tibotec Pharmaceuticals Ltd.	HIV inhibiting bicyclic pyrimdine derivatives
US7563781B2 (en)	2005-01-14	2009-07-21	Janssen Pharmaceutica Nv	Triazolopyrimidine derivatives
BRPI0611187A2 (pt)	2005-06-03	2010-08-24	Xenon Pharmaceuticals Inc	derivados aminotiazàis como inibidores da estearoil-coa desaturase humana
EP1904457B1 (en)	2005-06-08	2017-09-06	Rigel Pharmaceuticals, Inc.	Compositions and methods for inhibition of the jak pathway
US20070203161A1 (en) *	2006-02-24	2007-08-30	Rigel Pharmaceuticals, Inc.	Compositions and methods for inhibition of the jak pathway
JP2009506069A (ja)	2005-08-26	2009-02-12	ブレインセルス，インコーポレイティド	ムスカリン性受容体調節による神経発生
EP2258359A3 (en)	2005-08-26	2011-04-06	Braincells, Inc.	Neurogenesis by muscarinic receptor modulation with sabcomelin
US8119655B2 (en) *	2005-10-07	2012-02-21	Takeda Pharmaceutical Company Limited	Kinase inhibitors
US7985756B2 (en)	2005-10-21	2011-07-26	Braincells Inc.	Modulation of neurogenesis by PDE inhibition
WO2007053596A1 (en)	2005-10-31	2007-05-10	Braincells, Inc.	Gaba receptor mediated modulation of neurogenesis
JP2009528295A (ja)	2006-02-24	2009-08-06	ライジェルファーマシューティカルズ，インコーポレイテッド	Ｊａｋ経路の阻害のための組成物および方法
US20100216734A1 (en)	2006-03-08	2010-08-26	Braincells, Inc.	Modulation of neurogenesis by nootropic agents
WO2007134136A2 (en)	2006-05-09	2007-11-22	Braincells, Inc.	Neurogenesis by modulating angiotensin
US20100184806A1 (en)	2006-09-19	2010-07-22	Braincells, Inc.	Modulation of neurogenesis by ppar agents
SG158147A1 (en)	2006-10-09	2010-01-29	Takeda Pharmaceutical	Kinase inhibitors
NZ582349A (en) *	2007-06-29	2012-06-29	Sunesis Pharmaceuticals Inc	Heterocyclic compounds useful as raf kinase inhibitors
CL2008001933A1 (es)	2007-06-29	2009-09-25	Millennium Pharm Inc	Compuestos derivados de pirimidina, inhibidores de la raf quinasa; compuestos intermediarios; procedimiento de preparacion; composicion farmaceutica; y su uso para tratar trastornos proliferativos, cardiacos, neurodegenerativos, inflamatorios, oseos, inmunologicos enfermedad viral, entre otros.
WO2010099217A1 (en)	2009-02-25	2010-09-02	Braincells, Inc.	Modulation of neurogenesis using d-cycloserine combinations
BR112012029647A2 (pt)	2010-05-21	2016-08-02	Chemilia Ab	novos derivados de pirimidinas
JP5886411B2 (ja)	2011-03-24	2016-03-16	ノビガ・リサーチ・エービーＮｏｖｉｇａＲｅｓｅａｒｃｈＡＢ	新規のピリミジン誘導体
WO2013110309A1 (en) *	2012-01-28	2013-08-01	Merck Patent Gmbh	Triazolo[4,5-d]pyrimidine derivatives
JP6049768B2 (ja)	2012-03-07	2016-12-21	メルクパテントゲゼルシャフトミットベシュレンクテルハフツングＭｅｒｃｋＰａｔｅｎｔＧｅｓｅｌｌｓｃｈａｆｔｍｉｔｂｅｓｃｈｒａｅｎｋｔｅｒＨａｆｔｕｎｇ	トリアゾロピラジン誘導体
ES2636936T3 (es) *	2013-03-05	2017-10-10	Merck Patent Gmbh	Derivados de triazolo[4,5-d]pirimidina para el tratamiento de enfermedades tales como cáncer
US9617266B2 (en)	2013-03-05	2017-04-11	Merck Patent Gmbh	Imidazopyrimidine derivatives
CA2911259A1 (en)	2013-05-06	2014-11-13	Merck Patent Gmbh	Macrocycles as kinase inhibitors
EP3226861A2 (en) *	2014-12-05	2017-10-11	Centre National de la Recherche Scientifique (CNRS)	Compounds for treating cystic fibrosis
US11370793B2 (en)	2015-08-27	2022-06-28	Nantneuro, Llc	Triazolopyridines and triazolopyrimidines that lower stress-induced p-tau
WO2017156527A1 (en) *	2016-03-11	2017-09-14	H. Lee Moffitt Cancer Center And Research Institute, Inc.	Aurora kinase and janus kinase inhibitors for prevention of graft versus host disease
EP3920885A1 (en)	2019-02-08	2021-12-15	Frequency Therapeutics, Inc.	Valproic acid compounds and wnt agonists for treating ear disorders
WO2025104079A1 (en) *	2023-11-17	2025-05-22	Helmholtz-Zentrum für Infektionsforschung GmbH	Salicylic acid and picolinic acid derivatives as inhibitors of energy coupling factor (ecf) transporters for the treatment of bacterial infections

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5962594A (ja) *	1982-09-30	1984-04-10	Ss Pharmaceut Co Ltd	３，５―ジ置換―トリアゾロピリミジン誘導体
US20020040031A1 (en) *	2000-07-07	2002-04-04	Glasky Michelle S.	Methods for prevention of accumulation of amyloid beta peptide in the central nervous system
US6737085B2 (en) *	2000-11-01	2004-05-18	Tokiwa Phytochemical Co., Ltd.	Apocynum venetum extract for use as antidepressant
EP1347972A1 (en) *	2000-12-19	2003-10-01	Smithkline Beecham Plc	Pyrazolo 3,4-c]pyridines as gsk-3 inhibitors
ATE370142T1 (de) *	2003-07-16	2007-09-15	Janssen Pharmaceutica Nv	Triazolopyrimidinderivate als inhibitoren von glycogensynthasekinase-3

2004
- 2004-07-12 AT AT04766189T patent/ATE370142T1/de active
- 2004-07-12 MX MXPA06000540A patent/MXPA06000540A/es active IP Right Grant
- 2004-07-12 EP EP04766189A patent/EP1658292B1/en not_active Expired - Lifetime
- 2004-07-12 KR KR1020057024541A patent/KR20060120393A/ko not_active Ceased
- 2004-07-12 NZ NZ545058A patent/NZ545058A/en not_active IP Right Cessation
- 2004-07-12 WO PCT/EP2004/051455 patent/WO2005012307A1/en not_active Ceased
- 2004-07-12 ES ES04766189T patent/ES2290754T3/es not_active Expired - Lifetime
- 2004-07-12 JP JP2006519926A patent/JP2009514782A/ja not_active Withdrawn
- 2004-07-12 DK DK04766189T patent/DK1658292T3/da active
- 2004-07-12 PL PL04766189T patent/PL1658292T3/pl unknown
- 2004-07-12 US US10/564,844 patent/US7560458B2/en not_active Expired - Fee Related
- 2004-07-12 EA EA200600258A patent/EA010109B1/ru not_active IP Right Cessation
- 2004-07-12 AP AP2006003486A patent/AP2006003486A0/xx unknown
- 2004-07-12 AU AU2004260738A patent/AU2004260738B2/en not_active Ceased
- 2004-07-12 DE DE602004008303T patent/DE602004008303T2/de not_active Expired - Lifetime
- 2004-07-12 BR BRPI0412596-7A patent/BRPI0412596A/pt not_active IP Right Cessation
- 2004-07-12 JO JO200496A patent/JO2460B1/en active
- 2004-07-12 CA CA002531333A patent/CA2531333A1/en not_active Abandoned
- 2004-07-12 PT PT04766189T patent/PT1658292E/pt unknown
- 2004-07-12 CN CNB2004800201486A patent/CN100404536C/zh not_active Expired - Fee Related
- 2004-07-15 TW TW093121066A patent/TW200524935A/zh unknown
- 2004-07-15 AR ARP040102496A patent/AR045698A1/es not_active Application Discontinuation
- 2004-07-15 PA PA20048607001A patent/PA8607001A1/es unknown
2006
- 2006-01-12 IL IL173139A patent/IL173139A/en not_active IP Right Cessation
- 2006-01-13 ZA ZA200600385A patent/ZA200600385B/en unknown
- 2006-02-10 NO NO20060678A patent/NO20060678L/no not_active Application Discontinuation
2008
- 2008-09-16 US US12/211,361 patent/US20090036471A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EP1658292B1 (en)	2007-08-15
ES2290754T3 (es)	2008-02-16
TW200524935A (en)	2005-08-01
DE602004008303T2 (de)	2008-05-08
AR045698A1 (es)	2005-11-09
US20060205721A1 (en)	2006-09-14
ZA200600385B (en)	2007-05-30
AU2004260738A1 (en)	2005-02-10
JP2009514782A (ja)	2009-04-09
CA2531333A1 (en)	2005-02-10
DE602004008303D1 (de)	2007-09-27
PL1658292T3 (pl)	2008-01-31
EA010109B1 (ru)	2008-06-30
BRPI0412596A (pt)	2006-09-19
DK1658292T3 (da)	2007-11-12
CN1823068A (zh)	2006-08-23
PT1658292E (pt)	2007-10-25
WO2005012307A1 (en)	2005-02-10
AP2006003486A0 (en)	2006-02-28
IL173139A (en)	2010-04-29
IL173139A0 (en)	2006-06-11
NZ545058A (en)	2008-05-30
CN100404536C (zh)	2008-07-23
KR20060120393A (ko)	2006-11-27
US20090036471A1 (en)	2009-02-05
US7560458B2 (en)	2009-07-14
EA200600258A1 (ru)	2006-06-30
EP1658292A1 (en)	2006-05-24
PA8607001A1 (es)	2005-05-10
ATE370142T1 (de)	2007-09-15
JO2460B1 (en)	2009-01-20
AU2004260738B2 (en)	2009-07-16
MXPA06000540A (es)	2006-03-30

Legal Events

Date	Code	Title	Description
2011-02-28	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
JO2460B1 (en)	2009-01-20	Triso-pyrimidine derivatives acting as contraindications to the glycogen kinase-3 enzyme
WO2005012304A3 (en)	2007-04-26	Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
DK1442019T3 (da)	2008-01-14	Amidderivater som glycogensynthasekinase 3- beta-inhibitorer
CO6241157A2 (es)	2011-01-20	"derivados de 6-(pirrolidin-3-il)-1h-pirazolo{3,4-d}pirimidin-4(5h)-ona utiles como inhibidores de pde9"
CY1112642T1 (el)	2016-02-10	Παραγωγα 4-(πυριδιν-4-υλο)-1η-[1,3,5]τριαζιν-2-ονης ως αναστολεις της gsκ3-βετα για τη θεραπεια των νευροεκφυλιστικων ασθενειων
MX2021009763A (es)	2021-09-08	Derivados de 3-(1-oxo-5-(piperidin-4-il)isoindolin-2-il)piperidina -2,6-diona y usos de los mismos.
AR067327A1 (es)	2009-10-07	Derivados de piperidina / piperazina
NO2012010I2 (no)	2013-09-02	Rilpivirin samt farmasøytisk akseptable addisjonssalter derav innbefattende hydrokloridsaltet av Rilpivirin
NO20073960L (no)	2007-09-24	Pyrazolderivater for inhibering av CDK og GSK
NO20073926L (no)	2007-10-01	Pyrazolforbindelser som modulerer aktivitet av CDK-, GSK- og aurorakinaser
MX2012001661A (es)	2012-03-16	Mezclas de pesticidas mesoionicos.
DE60320012D1 (de)	2008-05-08	Aminoheterocyclen als vr-1 antagonisten zur behandlung von schmerzen
RU2009148320A (ru)	2011-07-20	Производные пиперидина/пиперазина
CY1114767T1 (el)	2016-12-14	Ν,ν-υποκατεστημενες ενωσεις 3-αμινοπυρρολιδινης χρησιμες ως αναστολεις επαναπροσληψης μονοαμινων
NO20071234L (no)	2007-05-08	Forbindelser som potensierer glutamatreseptor og anvendelse derav innen medisin
BR0211887A (pt)	2004-09-21	Derivados de triazolil 2-amino-4,5-trissubstituìdo
CO2020012353A2 (es)	2021-01-18	Compuestos de pirazol sustituidos con heteroarilo y uso farmacéutico de los mismos
AR066154A1 (es)	2009-07-29	Derivados de piperidina / piperazina
DE602007004740D1 (de)	2010-03-25	Antibiotische spiroderivate
EP1867331A4 (en)	2009-04-08	TRIAZOLE DERIVATIVE AND USE THEREOF
AR066605A1 (es)	2009-09-02	Derivados de heteroarilamida pirimidona
AR070073A1 (es)	2010-03-10	Derivados de imidazo[1, 2 - a]piridin-2-carboxamidas, intermediarios para su preparacion, una composicion farmaceutica que los comprende y su uso en la fabricacion de medicamentos para el tratamiento de enfermedades que implican a los receptores not.
PE20252682A1 (es)	2025-11-24	Derivados de oxazolo[4,5-b]pirazina y oxazolo[4,5-b]piridina como inhibidores de nlrp3 para el tratamiento de, por ejemplo, enfermedades inflamatorias
WO2006075023A3 (en)	2006-09-28	Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
WO2005095399A3 (fr)	2006-06-01	Derives pyrrolo (2,3-b) pyridine, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases